
Clorox (CLX) Stock Forecast & Price Target
Clorox (CLX) Analyst Ratings
Bulls say
Clorox has demonstrated a robust financial performance, exceeding internal sales expectations particularly in the Health & Wellness and International segments, attributed to increased consumption and favorable product mix. The company's earnings per share (EPS) of $1.86 significantly surpassed consensus estimates of $1.37, indicating strong profitability. Furthermore, Clorox has shown consistent market share growth across its various product categories for two consecutive quarters, reinforcing a positive outlook for future top-line growth.
Bears say
Clorox's stock outlook is negatively impacted by several fundamental factors, including anticipated organic sales growth remaining at the low end of the low single digits (+0-1%), primarily due to challenging comparisons from last year's recovery after a cybersecurity incident. Additionally, the company is facing supply chain challenges in key product categories such as bags and cat litter, which could further hinder the recovery of dollar sales and potential market share. Moreover, the rising risks associated with input costs and the highly competitive landscape in the consumer products sector underscore concerns about Clorox's ability to maintain profit margins and brand strength moving forward.
This aggregate rating is based on analysts' research of Clorox and is not a guaranteed prediction by Public.com or investment advice.
Clorox (CLX) Analyst Forecast & Price Prediction
Start investing in Clorox (CLX)
Order type
Buy in
Order amount
Est. shares
0 shares